Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia

Published:2017-07-17 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Climent Elisenda,Pérez-Calahorra Sofía,Marco-Benedí Victoria,Plana Nuria,Sánchez Rosa,Ros Emilio,Ascaso Juan F.,Puzo Jose,Almagro Fátima,Lahoz Carlos,Civeira Fernando,Pedro-Botet Juan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-06101-6.pdf

Reference30 articles.

1. Hovingh, G. K., Davidson, M. H., Kastelein, J. J. & O’Connor, A. M. Diagnosis and treatment of familial hypercholesterolaemia. Eur. Heart. J. 34, 962–971 (2013).

2. Cenarro, A. et al. The p.Leu167del mutation in APOE gene causes autosomal dominant hypercholesterolemia by down-regulation of LDL receptor expression in hepatocytes. J. Clin. Endocrinol. Metab. 101, 2113–2121 (2016).

3. Vohl, M. C. et al. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia. Eur. J. Clin. Invest. 27, 366–373 (1997).

4. Besseling, J., Kastelein, J. J., Defesche, J. C., Hutten, B. A. & Hovingh, G. K. Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA 313, 1029–1036 (2015).

5. Preiss, D. & Sattar, N. Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA. 313, 1016–1017 (2015).

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications;Diabetes Therapy;2024-07-30

2. Predictors of cardiovascular risk in familial hypercholesterolemia;Current Opinion in Endocrinology, Diabetes & Obesity;2024-05-08

3. Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?;Current Opinion in Lipidology;2024-04-19

4. Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia;Lipids in Health and Disease;2024-04-14

5. Predictors of cardiovascular risk in familial hypercholesterolemia;Current Opinion in Lipidology;2023-09-28